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Abstract
Escherichia coli is a frequent cause of clinical mastitis in dairy cows. It has been shown that a prompt response
of the mammary gland after E. coli entry into the lumen of the gland is required to control the infection, which
means that the early detection of bacteria is of prime importance. Yet, apart from lipopolysaccharide (LPS), little
is known of the bacterial components which are detected by the mammary innate immune system. We
investigated the repertoire of potential bacterial agonists sensed by the udder and bovine mammary epithelial
cells (bMEC) during E. coli mastitis by using purified or synthetic molecular surrogates of bacterial agonists of
identified pattern-recognition receptors (PRRs). The production of CXCL8 and the influx of leucocytes in milk
were the readouts of reactivity of stimulated cultured bMEC and challenged udders, respectively. Quantitative
PCR revealed that bMEC in culture expressed the nucleotide oligomerization domain receptors NOD1 and
N O D 2 ,a l o n gw i t ht h eT o l l - l i k er e c e p t o r sT L R 1 ,T L R 2 ,T L R 4 ,a n dT L R 6 ,b u th a r d l yT L R 5 .I nl i n ew i t he x p r e s s i o n
data, bMEC proved to react to the cognate agonists C12-iE-DAP (NOD1), Pam3CSK4 (TLR1/2), Pam2CSK4 (TLR2/
6), pure LPS (TLR4), but not to flagellin (TLR5). As the udder reactivity to NOD1 and TLR5 agonists has never
been reported, we tested whether the mammary gland reacted to intramammary infusion of C12-iE-DAP or
flagellin. The udder reacted to C12-iE-DAP, but not to flagellin, in line with the reactivity of bMEC. These results
extend our knowledge of the reactivity of the bovine mammary gland to bacterial agonists of the innate
immune system, and suggest that E. coli can be recognized by several PRRs including NOD1, but unexpectedly
not by TLR5. The way the mammary gland senses E. coli is likely to shape the innate immune response and
finally the outcome of E. coli mastitis.
Introduction
Mastitis is an important pathology in the dairy industry,
both in terms of economic impact and animal health.
Escherichia coli is among the major mastitis pathogens
responsible for clinical mastitis in cows [1-4]. The infec-
tion is initiated by the entry of the bacteria through the
teat canal and, after a short incubation period, is charac-
terized by an important inflammatory response and an
important influx of neutrophils into the udder [1,5].
Initiation of the inflammation is accompanied by the
production in milk of several molecules in the early stages
of infection such as the neutrophil chemo-attractants
CXCL8 and C5a and the proinflammatory cytokines
IL-1ß, IL-6 and TNFa [6,7].
A contribution of Mammary Epithelial Cells (MEC) to
the production of these different mediators has been
suggested by different authors [8-11]. Indeed, the incu-
bation of primary cell cultures of bovine Mammary
Epithelial Cells (bMEC) obtained from healthy animals
with bacteria, either E. coli or S. aureus, induces a
strong response [11-13].
Recognition of bacteria by host cells, for example
macrophages, dendritic cells or epithelial cells, relies
upon so called Pattern Recognition Receptors (PRR)
[14]. Such receptors belong to three different families
namely the Toll-like (TLR), NOD-like (NLR) and RIG-
1-like (RLR) receptors. Each of these receptors
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ciated Molecular Patterns (MAMPs). For example,
TLR4, TLR2 and TLR5 are respectively involved in
sensing lipopolysaccharide (LPS), lipoteichoic acid
(LTA) (and lipoproteins) and flagellin [14].
Homologues of human TLR receptors 1-10 have been
identified in bovine and were shown to be expressed at
different levels in the skin [15,16]. In the udder, the
expression of TLR2, TLR4 and NOD2 has been demon-
strated by several laboratories [17,18]. In agreement
with the expression of these receptors, infusion of puri-
fied bacterial compounds recognized by these PRR lead
to an inflammation of the udder mimicking the initial
response to experimental infections with live bacteria.
For example, infusion of LTA, muramyl-dipeptide
(MDP) and LPS have already been shown to induce a
neutrophil recruitment and to provoke symptoms simi-
lar, yet not identical, to those caused by live bacteria
[1,18]. Most importantly, it seems that these bacterial
agonists can act synergistically and increase the response
of the udder [18].
Of these agonists that trigger inflammation of the udder,
only LPS and MDP can be produced by E. coli strains and
contribute to the inflammation observed during bovine
mastitis. Yet, E. coli can also produce other agonists that
can contribute to this inflammation by triggering TLR2 or
other PRR such as TLR5 or NOD1. Actually, lipoproteins
from the E. coli envelope can be detected by the TLR2
receptor in combination with either TLR1 (for tri-acylated
lipoproteins) or TLR6 (for di-acylated lipoproteins) [14]. In
addition, TLR5 was shown to recognize flagellin, the major
constituent of flagella [19]. In human, NOD1 recognizes
peptidoglycan fragments composed of gamma-D-gluta-
myl-meso-diaminopimelic acid (iE-DAP) or N-acetylmura-
myl-L-alanyl-g-D-glutamyl- meso-diaminopimelic acid
(mur-TriDAP) [20].
Recognition of both flagellin and peptidoglycan frag-
ments is an important issue given the role these MAMPs
can play during an infection. Indeed, flagellin is a major
player in the recognition of mucosal pathogens [19].
NOD1 has also been demonstrated as an important med-
iator in controlling infections by, for example, Listeria
monocytogenes, Helicobacter pylori or entero-invasive
E. coli [21-23]. Furthermore, it was recently shown that
NOD1 could play a role in the maturation of the immune
system and that its stimulation could modify the response
of the host in a case of neutrophilic inflammation [24,25].
In order to better characterize how E. coli is recog-
nized by bMEC, we investigated the repertoire of E. coli
MAMPs that could be recognized by bMEC. MAMPs
tested are known agonists of different innate immune
receptors such as TLR2/TLR1 or TLR2/TLR6 heterodi-
mers, TLR4, TLR5, NOD1 and NOD2.
Materials and methods
Reagents
C12-iE-DAP (C12-D-g-Glu-mDAP), Tri-DAP (L-Ala-g-
D-Glu-mDAP), synthetic diacylated (Pam2CSK4) and
triacylated (Pam3CSK4) lipopeptide, ultra pure LPS
from E. coli K-12, bacterial flagellin from S. enterica ser-
ovar Typhimurium were obtained lyophilized from Invi-
voGen (Invivogen, France).
Agonists were made soluble in sterile pyrogen-free
water and then diluted in cell culture medium.
Experimentally induced mastitis
Healthy mid-lactating Holstein cows of the experimental
herd of the Institute at Nouzilly were selected on the
basis of an absence of detectable bacterial growth from
two weekly consecutive aseptically collected milk sam-
ples in their four mammary quarters and less than
100 000 cells/mL in milk. The cows were in their sec-
ond or third lactation and between 2 and 6 months in
lactation; they were milked twice a day, at 0800 and
1600 h. The use and care of the cows in this study were
approved by the Regional Committee of Ethics for Ani-
mal Experimentation (CREEA) (approval CL2007-47).
At time zero, five cows received in the lumen of quar-
ters through the teat canal either 0.5 mL RPMI 1640
medium (Gibco), C12-iE-DAP (10 μg), Tri-DAP (50 μg).
The fourth quarter was left untreated. A second group
of five cows received, at time zero, either 0.5 mL RPMI
1640 medium (Gibco) or purified flagellin (5, 1 or
0.1 μg). The infused quarters and the control quarter
were aseptically sampled just before the morning milk-
ing, and infusion was carried out within 30 min post
milking. The quarters were then sampled at 4, 8, 12, 24,
32, 48 and, in the case of NOD1 agonists, 72 h post
infusion (hpi). Cells in milk were counted with an auto-
mated cell counter (Fossomatic model90; Foss Food
Technology, Hillerod, Denmark) as described previously
[26]. The occurrence of new infections in the quarters
under experiment was verified by plating milk samples
onto blood agar plates. Results from quarters infected
during the experiment were discarded leading to the
removal of results from one quarter in the control
group of the each experiment, one quarter infused with
C12-iE-DAP and one infused with flagellin (1 μg).
Reverse transcription and qPCR analysis
Total RNA was extracted from bMEC by using the
NucleoSpin RNA II extraction kit (Macherey-Nagel,
Düren, Germany), and the residual genomic DNA was
removed by using DNase digestion with RNase-free
DNase (Macherey-Nagel). The total RNA quantity and
quality were assessed by using a NanoDrop spectrophot-
ometer (NanoDrop Technologies, Wilmington, DE,
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cDNA using random hexamers and SuperScript RT III
(Invitrogen) according to the manufacturer’s instructions.
Diluted cDNA samples were stored at 4°C until use. Pri-
mers used in this study are listed in Table 1. Relative
quantities of gene transcripts were measured as described
previously [27].
Quantification of CXCL8 by ELISA
CXCL8 concentrations were measured in skim milk by
ELISA as described [11,28]. The lowest limit of detec-
tion and level of quantification in milk were 0.01 and
0.03 ng/mL for CXCL8, respectively.
Culture and stimulation of bMEC
bMEC were isolated from five lactating cows as previously
described and cryopreserved in liquid nitrogen [10]. Cells
were used at their third passage and cultivated as described
[27]. Briefly, cells were seeded into 24-well tissue culture
plates at a density of 10
5 cells/well and cultured until con-
fluence in a growth medium made up of D-MEM-F12
advanced medium with 2 mM L-glutamine, 20 mM
HEPES, 50 μg/mL IGF-1, 10 μg/mL FGF, 10 μg/mL EGF
and 1 μg/mL hydrocortisone as additives. The growth
medium was then replaced with stimulation medium made
up of Advanced D-MEM-F12 medium with 2 mM L-gluta-
mine, 20 mM HEPES, and 4 ng/mL hydrocortisone as
additives. Stimulations with bacterial agonists were carried
out 16-24 h later. The medium was removed, and agonists
(uLPS, C12-iE-DAP, Pam2CSK4, Pam3CSK4, flagellin)
were added at the desired concentration in 1 mL of stimu-
lation medium. Control wells were treated with stimulation
medium only. 5 h after exposure to the MAMP, culture
m e d i u mw a sa s p i r a t e da n ds t o r e da t- 2 0 ° C .
Statistical analysis
Statistical analyses of the concentrations of CXCL8 or
SCC in milk were performed with the nonparametric
Friedman test. Comparisons of CXCL8 concentrations
in bMEC supernatants were done using the Kruskal and
Wallis test followed by multiple comparisons with a
Bonferoni correction. A P value < 0.05 was considered
significant.
Results
Multiple PRRs are expressed by bMEC
In a first attempt to characterize the repertoire of bacter-
i a la g o n i s t sr e c o g n i z e db yt h eb o v i n eu d d e r ,w ei n v e s t i -
gated the expression of different Pattern Recognition
Receptors (PRR) by RT-qPCR. PRR investigated are those
homologous to mammalian receptors involved in recog-
nition of LPS (TLR4), peptidoglycan (NOD1 and NOD2),
lipoproteins (TLR2, TLR1 and TLR6) and flagellin
(TLR5). Expression of all these PRRs was observed in the
bMEC preparations isolated from the five different cows
(Figure 1). Yet, expression of TLR5 was found to be
Table 1 List of primers used in this study
Gene Primer ID Primer sequence Size of amplicon Annealing temperature (°C)
18S 18sF CGGGGAGGTAGTGACGAAA 196 bp 62
18sR CCGCTCCCAAGATCCAACTA
ACTB ACTB f ACGGGCAGGTCATCACCATC 166 bp 64
ACTB r AGCACCGTGTTGGCGTAGAG
PPIA PPIA Fq TCCGGGATTTATGTGCCAGGG 206 bp 66
PPIA Rq GCTTGCCATCCAACCACTCAG
TLR1 TLR1 Fq ACCCTACTCTGAACCTCAAG 142 bp 62
TLR1 Rq GACTGCACACTGGATTTCTG
TLR2 TLR2 Fq ACTGGGTGGAGAACCTCATGGTCC 307 bp 62
TLR2 Rq ATCTTCCGCAGCTTACAGAAGC
TLR4 TLR4 F2q GCATGGAGCTGAATCTCTAC 238 bp 62
TLR4 R2q CAGGCTAAACTCTGGATAGG
TLR5 TLR5 Fq TTCCTGCAACCTCACCCAAG 192 bp 62
TLR5 Rq CTGAGATTGGGCAGGTTTCG
TLR6 TLR6 Fq CTCCGGGAGATAGTCACTTC 297 bp 62
TLR6 Rq GGCCCTGGATTCTATTATGG
NOD1 NOD1 F2q TGGTCACTCACATCCGAAAC 218 bp 62
NOD1 F2q AGGCCTGAGATCCACATAAG
NOD2 NOD2-f CCCAGGGGCTCAGAACTAACA 238 bp 62
NOD2-r CCTTCATCCTGGACGTGGTTC
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the PCR efficiencies were similar for all genes analyzed
(above 90%), the ΔCt value for TLR5 was on average
between 3 and 9 cycles above that of other genes. On the
contrary, TLR4 and NOD1 were the most highly
expressed receptors.
bMEC respond to stimulation by LPS, peptidoglycan
fragments but not flagellin
To investigate whether these transcription results trans-
lated into functional differences we investigated the
response of bMEC to the different agonists recognized
by these PRRs. Results obtained confirmed previous stu-
dies showing that bMEC respond to stimulation by ago-
nists such as LPS, MDP or LTA by the production of
CXCL8 (Figure 2 and data not shown) [18]. As all
bMEC used in this study also express receptors for
peptidoglycan fragments and lipoproteins, we investi-
gated whether this was correlated to response to these
compounds. Our results demonstrate that the NOD1
agonist C12-iE-DAP induces the production of CXCL8
in a dose dependent manner starting at 100 ng/mL
C12-iE-DAP (Figure 2). bMEC also responded to
Pam3CSK4 and Pam2CSK4, two lipoprotein analogs
respectively agonists of the heterodimer receptors
TLR1/2 and TLR2/6 (Figure 2). Interestingly, a strong
response was observed with as little as 10 ng/mL of
Pam2CSK4 and this response was not increased when
using 100 ng/mL or 1000 ng/mL concentrations. Con-
sistent with the low transcription of TLR5 by bMEC,
these cells failed to respond to flagellin in a significant
manner: indeed, even at a high concentration (1000 ng/
mL), a very low production of CXCL8 was observed
(Figure 2).
Altogether, these results indicate that, in addition to
LPS, bMEC are able to sense and respond to TLR2,
NOD1 and NOD 2 agonists but not to TLR5 agonists.
The response of the udder to bacterial agonists mimics
that of bMEC
Among the above tested agonists, Pam2CSK4 and
Pam3CSK4 are supposed to act through stimulation of
TLR2, a receptor that is known to be both expressed in
vivo at the surface of mammary epithelial cells and
functional as demonstrated by intramammary infusion
of LTA [11,17]. We therefore focused our in ubero stu-
dies on receptors whose activation had never been stu-
died previously in the cow.
We therefore tested the capacity of TLR5 and NOD1
agonists to induce inflammation when infused in the udder.
C12-iE-DAP was infused in the mammary gland of 5 cows
and we monitored the somatic cell count (Figure 3a) as
well as the CXCL8 production in milk (Figure 3b). Our
results clearly establish that this agonist induced cellular
recruitment and CXCL8 production. Increased SCC com-
pared to the control quarter was observed as early as
12 hpi. On the contrary, the use of another NOD1 agonist,
Tri-DAP, failed to induce both a significant cellular recruit-
ment and CXCL8 production in milk.
Flagellin was infused in the udder of 5 cows at three
different doses, up to 5 μg: in all cases, no significant
cellular recruitment was observed, consistent with the
lack of TLR5 expression and response of bMEC to fla-
gellin (Figure 4).
Discussion
This study was undertaken in order to understand how
E. coli can be sensed by the mammary gland and to bet-
ter characterize the potential contribution of bMEC to
t h ei n f l a m m a t i o no ft h eu d d e r .T h er o l eo fb M E Ci n
initiating the inflammation has been suggested by
Figure 1 Expression of PRR by bMEC. Quantitative RT-PCR was
performed on RNA obtained from bMEC isolated from 5 different
cows. ΔCt values (Ct target–Ct for ß-actin gene) for each bMEC are
represented on the graph. PCR efficiency was above 90% for all
genes and Ct were obtained for an identical fluorescence threshold
for all genes.
Figure 2 CXCL8 secretion by bMEC after stimulation with
different bacterial agonists. bMEC from five different cows were
seeded in 24-well plates at a concentration of 10
5 cells/well.
Twenty-four hours prior to stimulation, the culture medium was
replaced by stimulation medium. Cells were incubated in the
presence of different purified agonists at the indicated
concentrations. CXCL8 concentration in the supernatant was
measured by ELISA 5 h after initiation of the stimulation. Data are
median values and interquartile ranges. *statistical significance (P <
0.05) of values from stimulated versus unstimulated bMEC.
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respond to different bacterial stimuli. In this study we
investigated in more details the bacterial compounds
that could be recognized by bMEC and whether these
compounds were able to induce inflammation when
infused into the udder. By a combination of transcrip-
tion data, in vitro stimulation of bMEC and in ubero
experiments we confirmed previous studies and showed
for the first time that NOD1 could play a role in bovine
mastitis while, on the contrary, TLR5 is not likely to be
an important contributor to the inflammation of the
udder.
More precisely, our results show for the first time that
peptidoglycan fragments known to activate the NOD1
receptor in other mammals could be recognized by
bMEC and are able to induce inflammation in ubero.
This result is all the more important given the multiple
activities that the NOD1 receptor is likely to play. Apart
f r o mar o l ei nt r i g g e r i n gt h ei n n a t ei m m u n er e s p o n s e ,
activation of NOD1 could also contribute to a more effi-
cient reduction of the pathogen load by neutrophils as
was shown in other infections [29]. Yet, we only
observed inflammation of the udder with C12-iE-DAP
and not with Tri-DAP. The major difference between
these two agonists is that C12-iE-DAP is rendered
m e m b r a n ep e r m e a b l eb yal i p o p h y l i cm o i e t yw h i c h
allows the molecule to better enter the host cell and
activate NOD1 [30]. Indeed, the NOD1 receptor is cyto-
plasmic and its activation requires that the agonist is
transported into the host cell [31].
The failure to induce inflammation of the udder with
Tri-DAP is therefore likely to result from the lack of
access of this agonist to the cytoplasm of host cells.
Nevertheless, during the course of mastitis, it is possible
that peptidoglycan fragments recognized by NOD1 can
reach the cytoplasm of bovine cells following invasion of
epithelial cells by E. coli. Indeed, invasion of mammary
epithelial cells has been described for some strains of
E. coli involved in recurrent mastitis cases [32]. Further-
more, expression of membrane transporters under parti-
cular circumstances like inflammation could transport
peptidoglycan fragments, as was shown for MDP, a
NOD2 agonist [18,33].
Most interestingly, we demonstrated that the TLR5
gene was only weakly transcribed and, consistently, that
bacterial flagellin was not recognized by bMEC and did
not induce inflammation of the udder. The failure of
purified flagellin to induce inflammation of the udder
was not expected since it is considered an important
target of mucosal immunity [34]. Although the flagellin
used in this study was purified from S. enterica serovar
Figure 3 A–Somatic cell counts (SCC) in quarters infused with
C12-iE-DAP 10 μg( ☐), Tri-DAP 50 μg( △) or control quarter (◊).
B–CXCL8 concentration in milk from quarters infused with C12-iE-
DAP 10 μg( ☐), Tri-DAP 50 μg( △) or control quarter (◊). Purified
agonists were infused into the udder of five different cows. SCC and
CXCL8 were quantified in milk 4, 8, 12, 24, 32, 48 h post-infusion.
Data are median values and interquartile ranges. *statistical
significance (P < 0.05) of values before and after treatment.
Figure 4 Somatic cell counts (SCC) in quarters infused with
flagellin 0.1 μg( ☐), flagellin 1 μg( △); flagellin 5 μg (×) or
control quarter (◊). Purified agonists were infused into the udder
of five different cows. SCC and CXCL8 were quantified in milk 4, 8,
12, 24, 32, 48 h post-infusion. Data are median values and
interquartile ranges. *statistical significance (P < 0.05) of values
before and after treatment.
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TLR5 receptors. Furthermore, the region of flagellin
recognized by TLR5 is located in one of the two con-
served regions of flagellin and is present both in Salmo-
nella Typhimurium and E. coli flagellin [19,35]. It is
therefore likely that, as for Salmonella Typhimurium fla-
gellin, E. coli flagellin will not be detected by bMEC and
does not contribute to the inflammation of the udder
during E. coli mastitis.
Still, it is possible that TLR5 contributes to the
response of the host when the infection worsens. In other
pathologies, stimulation of TLR5 in epithelial cells is pre-
cluded by the basolateral localization of TLR5 and only
occurs as a consequence of tissue damage whereby flagel-
lin gets in contact with TLR5 receptors [36]. This situa-
tion is often the result of invasive pathogens and, in some
instances, could occur in severe E. coli mastitis cases.
One could also speculate that expression of TLR5 could
be induced upon activation of other PRRs. Aside from
detection by TLR5, flagellin, when translocated to the
cytoplasm of the host cell, is also known to activate the
inflammasome through stimulation of NLRC4 (also
called IPAF) [37]. However, the contribution of this path-
way to the response of the host to flagellin is still under
debate [34]. The udder unresponsiveness to flagellin also
suggests that milk macrophages were either too few or
not reactive enough to set up inflammation.
Altogether, the above results support the idea that flagel-
lin is not a critical motif for the early detection of E. coli in
the healthy udder, neither through the activation of TLR5
nor that of NLRC4. Interestingly, proteomic analysis of the
mastitis E. coli strain P4 have shown that expression of fla-
gellin is decreased when bacteria are grown in milk com-
pared to conventional laboratory growth medium [38].
Our results also show that bMEC are also able to sense
the presence of lipoproteins through the TLR1/2 and
TLR2/6 heterodimers. Both agonists used in this study
induced a significant response of bMEC, Pam2CSK4
being more potent than Pam3CSK4 at inducing CXCL8
secretion by bMEC. Such results are not surprising since
expression of the TLR2 receptor has already been shown
in bMEC and was increased in infected udders [8,17]. In
addition, infusion of the TLR2 agonist LTA in the udder
of cows was shown to induce inflammation [18]. A new
finding of this study is that bMEC reacted strongly to
much lower concentrations of Pam2CSK4 than to
Pam3CSK4. This higher reactivity is in line with the
higher expression of TLR6 compared to TLR1 by bMEC.
Nevertheless, although di-acyl lipoproteins can be found
in E. coli,m o s tE. coli lipoproteins are tri-acylated pro-
teins [39]. It is therefore likely that the response of
bMEC to Pam3CSK4 resembles most to that induced by
E. coli lipoproteins.
Regarding the specificity of bovine PRRs, one should
bear in mind that the specificity of these receptors might
not be strictly identical to that of human/mouse PRRs, as
reviewed by Werling et al. [40]. These authors actually
state that bovine TLR1/TLR2 heterodimers could sense
both Pam2CSK4 and Pam3CSK4. Concerning TLR5, stu-
dies with Salmonella Typhimurium flagellin indicated that
it could activate bovine TLR5 expressing macrophages
[41]. The specificities of bovine NOD1 and NOD2 recep-
tors have not been characterized so far.
Investigations described in this manuscript were
obtained with purified agonists used alone. Our recent
results with MDP and LTA indicate that agonists can act
synergistically. Because a bacterium expresses several
MAMPs at a time such a synergy is likely to best mimic
what bMEC are exposed to during E. coli mastitis. Synergy
between MAMPs has already been observed in other mod-
els: in mice, for example, inoculation of LPS after an MDP
treatment increases the immune response [42]. Synergy
has also been observed with human monocytes and den-
dritic cells [43]. Our preliminary data indicate that such a
synergy may exist in ubero between LPS and MDP (data
not shown). The relevance of these potential synergies is
important in that it is likely to improve the recognition of
an udder pathogen and lead to an early response of the
host, which impacts the outcome of infection.
A corollary would be to study how different E. coli
strains stimulate each of these different PRRs. Because our
results were obtained with purified generic compounds,
they do not necessarily reflect the full diversity of E. coli
MAMPs that can be recognized. Indeed, the E. coli species
is very diverse: recent genomic studies have shown that of
the 4500-5000 genes that one E. coli strain might contain
only approx. 1800 genes are found in all E. coli strains
[44]. Mastitis E. coli isolates has only been incompletely
characterized. The presence of different genes character-
ized as virulence factors in other E. coli pathotypes has
been investigated by several authors but none has been
shown to be highly prevalent in mastitis E. coli strains.
Recently, a preliminary study showed that the prototypical
E. coli mastitis strain P4 contains several unique regions
[45]. Although no potential virulence genes have been
identified as specific of mastitis E. coli strains, the way
E. coli stimulates the host cells might play a role in the
inflammation of the udder.
In conclusion, bMEC are equipped with innate immu-
nity receptors that allow them to sense several E. coli
MAMPs. Overall, expression of PRRs as expressed by
qPCR mirrored the reactivity of bMEC as assessed by the
production of CXCL8, and the results obtained in bMEC
in vitro were in good agreement with the in ubero studies.
Such findings are in line with the concept that bMEC are
key players in initiating neutrophil inflammation during
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could contribute to the onset of an early response of the
cow after infection by E. coli. These results pave the way
to a better understanding of the early steps of the inflam-
mation triggered by E. coli entrance into the udder. The
precise contribution of the different PRR to this response
is now necessary and deserves further studies.
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